90-minute Science of Reading-based training now available for download at no cost to teachers, schools

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.

COVID Management Platform Aims to Become Leader in Emerging Constituent Health Services Industry

Gabtech Global invites your business into the future of Recruitment Process Outsourcing. Solve the uncertainty in the times of Pandemic, get access to new talent pools and ensure faster hires at much lower operational costs.

Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris System™, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

ViroMusic.io has launched an NFT collection of 10,000 songs literally made by the virus.

Hyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

A philanthropic event that gives back to their local community throughout December.

Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

As new mutations of SARS-CoV-2 keep spreading worldwide, Hyris keeps monitoring its test kits effectiveness, performing routine analysis of SARS-CoV-2 variants to safeguard public health and the product's quality by assessing the potential impact of new strains on sensitivity and specificity.

Go maskless, when allowed, without people thinking you are unvaccinated.

This means VR and AR users will be better protected from pathogens like Covid-19 while sharing equipment for education, enterprise or military XR programs.

U.S. nonprofit donates oxygen concentrators to community health centers and district health facilities in 10 states

Think expands its production to the United States with a series of investigative documentaries called "Traveling Through a Divided America."

As COVID-19 continues to impact India's population, Genealogy and Pulse are teaming up to study how genetics plays a role in the severity of the virus.

California Arts and Entertainment Industry Welcome Back Patrons With CDC Guidelines

Additional EUA claims enable validated full automation of SARS-CoV-2 IgG Test System

Automated, dual antigen serological testing for SARS-CoV-2 total antibodies now EUA approved and ready to ship.

LendingUSA, an award-winning point-of-sale solution for consumer financing, is a major player in the funeral industry. Their team is ready to assist funeral professionals in navigating the application and reimbursement process for FEMA's new funeral assistance program.

A healthcare campaign platform that empowers cities, counties, states, non-profits, foundations, and companies to book healthcare campaigns

FidaLab has partnered with Concentric by Ginkgo to support America's K-12 schools by offering pooled COVID-19 testing in Washington.

P23 Labs saliva-based 'P23 at-home COVID-19 Test Collection Kit' is first of its kind approved by Health Canada

MindBeauty shares why wearing a facemask while exercising is a must.

The new survey asked 272 licensed doctors in 78 countries their thoughts about the authorized COVID-19 vaccines.

Have investments or rentals? Earn over $80K? Here's How-to-Make-Taxes a Snap.

New live vaccine tracker shows the progress of vaccinations in the U.S.

The nation's COVID-19 vaccine and testing centers, medical facilities, hospitals and public service municipalities are tapping OnHold.com to help ease their inbound call burden with compassionate, instructive telephone greetings and accurate on-hold messaging.

Stars Join Kings and Queens for Causes to Help Hospitalized Kids and Save LGBTQ+ Safe Spaces

In 2021, masks are more than PPE. They're a first impression.

Airline-Industry-Driven Health Certification Centered Around Customers, Expected to Further Drive Global Airline Leadership in COVID-19 Safety

A telehealth app with AI for users to stay on top of their health will be globally available with over 10,000 subscriptions to the app before its release is timely with coronavirus end not in clear sight. Trends in younger patients show that even after COVID-19 is over, telehealth will be a new norm. Awarded the Telehealth Award at the House of Lords Euroknowledge Awards, the global release of this AI detailed telehealth app has sparked the investment market.

Giveaway attended by Congresswomen Meng